TAUNS Laboratories,Inc. (TYO:197A)

Japan · Delayed Price · Currency is JPY

521.00

-38.00 (-6.80%)

Feb 16, 2026, 3:30 PM JST

-5.10% (1Y)

Market Cap	55.44B -12.8%
Revenue (ttm)	14.58B -7.0%
Net Income	3.98B +31.0%
EPS	37.05 +22.1%
Shares Out	106.40M
PE Ratio	14.06
Forward PE	10.37
Dividend	28.00 (5.01%)
Ex-Dividend Date	Jun 29, 2026

Volume	1,712,800
Average Volume	558,245
Open	520.00
Previous Close	559.00
Day's Range	514.00 - 525.00
52-Week Range	418.00 - 618.00
Beta	n/a
RSI	41.56
Earnings Date	Feb 13, 2026

About TAUNS Laboratories,Inc.

TAUNS Laboratories,Inc. engages in the development, manufacture, export/import, and sale of in vitro diagnostics and research reagents, and its intermediates in Japan and internationally. The company also offers medical physicochemical measuring equipment, industrial measuring equipment, and medical devices; and contract research services. The company was founded in 1987 and is headquartered in Izunokuni, Japan. [Read more]

Industry Medical - Specialties

Sector Healthcare

Founded 1987

Employees 218

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 197A

Full Company Profile

Financial Performance

In fiscal year 2025, TAUNS Laboratories,Inc.'s revenue was 18.63 billion, an increase of 1.05% compared to the previous year's 18.43 billion. Earnings were 6.32 billion, an increase of 9.38%.

Financial Statements